DXR Stock Analysis: Buy, Sell, or Hold?
DXR - Daxor Corporation Common Stock
$10.65
0.54 (5.34%)
▲
5d:
+1.43%
30d:
+9.12%
90d:
+20.07%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Get Alerted When DXR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: DXR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: DXR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: DXR is currently trading at $10.65, which is considered extended relative to its 30-day fair value range of $9.74 to $10.50.
Technical Outlook: Technically, DXR is in a strong downtrend. Immediate support is located at $9.61, while resistance sits at $11.16. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: DXR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $22.50 (+111.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DXR is in a strong downtrend. Immediate support is located at $9.61, while resistance sits at $11.16. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: DXR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $22.50 (+111.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.74 -
$10.50
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
68.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.3%)
- BULLISH: Trading 111.3% below Wall St target ($22.50)
Trading Range Analysis
30-Day Trading Range
$9.74 -
$10.50
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$9.61
Resistance Level
$11.16
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-355.00
Wall Street Target
$22.50
(+111.3%)
Revenue Growth (YoY)
-82.6%
Earnings Growth (YoY)
329.3%
Profit Margin
34359.2%
Share & Embed Analysis
Last updated: July 14, 2026 7:46 PM ET
Data refreshes hourly during market hours. Next update: 8:46 PM
Data refreshes hourly during market hours. Next update: 8:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DXR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Michael Richard Feldschuh
BUY
1000 shares
2026-04-08
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 64 BUY |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$562 | 45 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$177 | 56 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$366 | 63 BUY |
|
RMD
ResMed Inc |
BUY
19 analysts |
$256 | 50 HOLD |
